Labelling pattern obtained by non-isotopic in situ hybridization as a prognostic factor in HPV-associated lesions

Journal of Pathology

Volumn 179, Issue 3, 1996, Pages 272-275

  Gómez, Fernando ^a   Picazo, Ana ^a   Roldán, Manuel ^a   Corcuera, María Teresa ^a   Curiel, Isabel ^a   Muñoz, Elisa ^b   Martínez, Ricardo ^a   Alonso, María José ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

human papillomavirus (HPV); non isotopic in situ hybridization (NISH); prognosis; squamous cell carcinoma; squamous intraepithelial lesion

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GRADING; CANCER RISK; DNA PROBE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VULVA CANCER; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; HUMANS; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 0029816022     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199607)179:3<272::AID-PATH599>3.0.CO;2-E     Document Type: Article

References (26)

1. Morgan D, Percoraro G, Rosenberg I, Defendi V. Transformation of C127 mouse fibroblasts by human papillomavirus 16, Cancer Res 1988; 48: 2505-2511.
2. Yasumoto S, Burkhardt AL, Doniger J, DiPaolo JA. Human papillomavirus type 16 DNA induced malignant transformation of NIH 3T3 cells. J Virol 1986; 57: 572-577.
3. Watanabe S, Yoshiike K. Transformation of rat 3Y1 cells by human papillomavirus type 18 DNA. Int J Cancer 1988; 41: 896-900.
4. Kaur P, McDougall JK. Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol 1988; 62: 1917-1924.
5. Pirisi L, Yasumoto S, Feller M, Doniger J, Di Paulo JA.,Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 1987; 61: 1061-1066.
6. Schwartz E, Freese UK, Gissman L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314: 111.
7. Spalholz BA, Wang Y-C, Howley PM. Transactivation of a bovine papillomavirus transcriptional regulatory element by the E2 gene product. Cell 1985; 42: 183-191.
8. Androphy EJ, Lowy DR, Schiller JT. Bovine papillomavirus E2 transactivating gene product binds to specific sites in papillomavirus DNA. Nature 1987; 325: 70-73.
9. Phelps WC, Yee CL, Munger K, Howley PM. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 1988; 53: 539.
10. Smotkin D, Wettstein FO. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 1986; 83: 4680-4684.
11. Seedorf K, Oltersdorf T, Krammer G, Rowemkamp W. Identification of early proteins of the human papillomavirus type 16 (HPV 16) and 18 (HPV 18) in cervical carcinoma cells. EMBO J 1987; 6: 139-144.
12. Halbert CL, Galloway DA. Identification of the E5 open reading frame of human papillomavirus type 16. J Virol 1988; 62: 1071-1075.
13. Shen S-L, Mounts P. Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells. J Virol 1990; 64: 3226-3233.
14. Herrington CS. Human papillomavirus and cervical neoplasia. I. Classification, virology, pathology, and epidemiology. J Clin Pathol 1994; 47: 1066-1072.
15. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D. In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo. J Clin Pathol 1991; 44: 400-405.
16. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D. In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa. J Clin Pathol 1991; 44: 406-409.
17. Cooper K, Herrington CS, Stickland JE, Evans MF. McGee JO'D. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol 1991; 44: 990-996.
18. Gómez F, Corcuera MT, Muñoz E, et al. Diagnosis of genital infection caused by human papillomavirus using in situ hybridisation: the importance of the size of the biopsy specimen. J Clin Pathol 1995; 48: 57-58.
19. Mincheva A, Gissman L, Zur Hausen H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by the in situ hybridisation. Med Microbiol Immunol 1987; 176: 245-256.
20. Yliskoski M, Tervahauta A, Saarikoski S, Mantyjarvi R, Syrjanen K. Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections. Sex Transm Dis 1992; 19: 137-139.
21. Barton SE, Hollingworth A, Maddox PH, et al. Possible cofactors in the etiology of cervical intraepithelial neoplasia. An immunopathologic study. J Reprod Med 1989; 34: 613-616.
22. Hildesheim A, Reeves WC, Brinton LA, et al. Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers. Int J Cancer 1990; 45: 860-864.
23. Mougin C, Schaal JP, Bassignot A, et al. Detection of human papillomavirus and human cytomegalovirus in cervical lesions by in situ hybridization using biotinylated probes. Biomed Pharmacother 1991; 45: 353-357.
24. Burger MP, Hollema H, Gouw AS, Pieters WJ, Quint WG. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. Br Med J 1993; 306: 749-752.
25. Herrington CS. Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors. J Clin Pathol 1995; 48: 1-6.
26. Pöllänen R, Vuopala S, Lehto VP. Detection of human papillomavirus infection by non-isotopic in situ hybridisation in condylomatous and CIN lesions. J Clin Pathol 1993; 46: 936-939.